MARKET

SESN

Sesen Bio, Inc.
SESN
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-4.6308
22.32
4.166
661,349,656.50
CARISMA THERAPEUTICS INC - INITIAL DATA EXPECTED BY YEAR-END 2024
Reuters · 05/16 11:30
CARISMA THERAPEUTICS, INC. <CARM.O>: H.C. WAINWRIGHT CUTS TARGET PRICE TO $8 FROM $9
Reuters · 05/10 10:33
CARISMA THERAPEUTICS INC <CARM.O>: EVERCORE ISI CUTS TARGET PRICE TO $4 FROM $12
Reuters · 05/10 10:27
CARISMA THERAPEUTICS APPOINTS DR. EUGENE P. KENNEDY AS CHIEF MEDICAL OFFICER
Reuters · 05/02 11:30
CARISMA THERAPEUTICS INC <CARM.O>: BTIG INITIATES COVERAGE WITH BUY RATING ; TARGET PRICE $6
Reuters · 04/11 11:58
CARISMA THERAPEUTICS, INC. <CARM.O>: H.C. WAINWRIGHT CUTS TARGET PRICE TO $9 FROM $11
Reuters · 04/02 10:08
Carisma Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Carisma Therapeutics Inc reports results for the quarter ended in December. The company reported a quarterly adjusted loss of 52 cents per share. Revenue was $4.29 million; analysts expected a loss of $20.96 million. The shares have lost 22.5% so far this year.
Reuters · 04/01 14:07
CARISMA THERAPEUTICS: CASH & CASH EQUIVALENTS AS OF DECEMBER 31, 2023, COMBINED WITH RESTRUCTURING OF OPERATIONS EXPECTED TO FUND COMPANY INTO Q3 2025
Reuters · 04/01 12:35
More

Webull offers Sesen Bio, Inc. stock information, including NASDAQ: SESN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SESN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SESN stock methods without spending real money on the virtual paper trading platform.